BioCentury
ARTICLE | Company News

BioVisioN, ImVisioN GmbH deal

May 30, 2005 7:00 AM UTC

ImVisioN acquired rights to BioVision's IP covering the MAT (Modular-Antigen-Transport) technology. ImVisioN also acquired exclusive rights to a patent application covering the recombinant expression ...